Lupin Pharmaceuticals, Inc. is a wholly owned subsidiary of Lupin Limited U.S. It’s sales and marketing headquarters is located in Baltimore, MD.
Lupin Pharmaceuticals, Inc. is providing high quality consistent services to deliver branded and generic medications trusted by healthcare professionals and patients across the globe.
Lupin Limited, headquartered in Mumbai, India, is strongly research focused, innovation driven.
It has a dedicated product development team consisting highly qualified experienced research scientists that works 24*7 for product innovation and development. The company has a state-of-the-art, highly equipped R&D center in Pune. It is a leading global player in Anti-TB, Cephalosporins (anti-infectives) and Cardiovascular drugs (ACE-inhibitors and cholesterol reducing agents) and it has a remarkable presence in the areas of acute diabetes, anti-inflammatory and respiratory therapies .It has been growing as the fastest generic pharmaceutical giant in the two largest pharma markets of the world – the United States and Japan; and is the 4th largest and the fastest growing generic pharmaceutical player in South Africa. Lupin’s research program is typically designed to cover the entire pharma value chain. The company’s global R&D program is headquartered in the Lupin Research Park located near Pune that houses over 1400 scientists.
Some of its well-recognized brands are Norvasc, Trizivir, Creftin. Lexapro, Mevacor, Pravacol etc.